1. Home
  2. COLM vs TARS Comparison

COLM vs TARS Comparison

Compare COLM & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

N/A

Current Price

$59.44

Market Cap

3.0B

ML Signal

N/A

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$71.49

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLM
TARS
Founded
1938
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.7B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
COLM
TARS
Price
$59.44
$71.49
Analyst Decision
Buy
Buy
Analyst Count
7
6
Target Price
$62.50
$89.00
AVG Volume (30 Days)
694.1K
708.6K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.00%
N/A
EPS Growth
N/A
48.21
EPS
1.17
N/A
Revenue
$3,042,478,000.00
$451,360,000.00
Revenue This Year
$3.73
$56.43
Revenue Next Year
$3.29
$30.19
P/E Ratio
$51.55
N/A
Revenue Growth
N/A
146.71
52 Week Low
$47.48
$48.20
52 Week High
$69.06
$85.25

Technical Indicators

Market Signals
Indicator
COLM
TARS
Relative Strength Index (RSI) 48.54 63.61
Support Level $56.41 $60.95
Resistance Level $65.02 $73.45
Average True Range (ATR) 1.46 3.29
MACD 0.31 0.84
Stochastic Oscillator 65.64 83.31

Price Performance

Historical Comparison
COLM
TARS

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: